The global market for Male Urinary Incontinence was estimated at US$6.1 Billion in 2025 and is projected to reach US$8.6 Billion by 2032, growing at a CAGR of 5.1% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The demand for effective and discreet management options, including absorbent pads, external urinary collection devices, pelvic floor therapy, and surgical implants, is increasing as more men seek medical treatment. Innovations in adjustable urinary sphincters, bioengineered implants, and neurostimulation therapies are also contributing to the expanding landscape of urinary incontinence solutions.
The development of non-invasive neuromodulation techniques, which stimulate nerve signals to improve bladder control, is also gaining traction. Custom-fitted urinary incontinence management devices and reusable, eco-friendly absorbent products are further enhancing convenience and sustainability in male UI care.
Additionally, greater healthcare accessibility and the rise of telemedicine consultations are making it easier for men to seek treatment without stigma. Insurance companies and government healthcare programs are also expanding reimbursement coverage for advanced UI treatments, driving more patients toward medical intervention rather than self-managed solutions.
The growing presence of male-specific wellness clinics and specialized urology treatment centers is further contributing to market expansion. As more men prioritize health and active lifestyles, the demand for discreet, comfortable, and effective urinary incontinence treatments continues to rise.
Global Male Urinary Incontinence Market - Key Trends & Drivers Summarized
Why Is Male Urinary Incontinence Gaining Importance?
Male urinary incontinence (UI) is a growing health concern, particularly among aging populations and men who have undergone prostate surgery, radiation therapy, or suffer from neurological conditions. It significantly impacts quality of life, leading to physical discomfort, emotional distress, and social embarrassment. The increasing awareness of available treatments and advancements in non-invasive and surgical interventions are driving the market for male urinary incontinence solutions.The demand for effective and discreet management options, including absorbent pads, external urinary collection devices, pelvic floor therapy, and surgical implants, is increasing as more men seek medical treatment. Innovations in adjustable urinary sphincters, bioengineered implants, and neurostimulation therapies are also contributing to the expanding landscape of urinary incontinence solutions.
How Are Innovations Enhancing the Performance of Male Urinary Incontinence Treatments?
Technology is playing a vital role in improving UI treatment outcomes. Smart wearable pelvic floor therapy devices equipped with biofeedback and AI-driven guidance are helping men regain bladder control without surgery. Additionally, hydraulic sphincter implants and biocompatible slings are improving comfort and long-term efficacy for surgical patients.The development of non-invasive neuromodulation techniques, which stimulate nerve signals to improve bladder control, is also gaining traction. Custom-fitted urinary incontinence management devices and reusable, eco-friendly absorbent products are further enhancing convenience and sustainability in male UI care.
What Are the Key Market Drivers?
The increasing prevalence of post-prostatectomy incontinence (PPI), obesity-related UI, and diabetes-induced bladder dysfunction is fueling market growth. Aging demographics, particularly in North America and Europe, are leading to higher adoption rates of urinary incontinence solutions, as men over 60 are more likely to experience UI.Additionally, greater healthcare accessibility and the rise of telemedicine consultations are making it easier for men to seek treatment without stigma. Insurance companies and government healthcare programs are also expanding reimbursement coverage for advanced UI treatments, driving more patients toward medical intervention rather than self-managed solutions.
The growing presence of male-specific wellness clinics and specialized urology treatment centers is further contributing to market expansion. As more men prioritize health and active lifestyles, the demand for discreet, comfortable, and effective urinary incontinence treatments continues to rise.
What Challenges and Future Opportunities Exist?
Challenges include lack of awareness and social stigma preventing men from seeking early medical intervention. Additionally, high costs associated with surgical treatments and limited reimbursement coverage in certain regions hinder adoption. However, emerging AI-powered biofeedback therapy, robotic-assisted incontinence surgeries, and minimally invasive neuromodulation techniques present future growth opportunities. Expansion into developing markets with affordable treatment options could further drive industry growth.Report Scope
The report analyzes the Male Urinary Incontinence market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:- Segments: Product (Male Urinary Incontinence Non-Absorbent, Male Urinary Incontinence Absorbents); Incontinence (Stress Urinary Incontinence, Urge Urinary Incontinence, Overflow Incontinence, Functional Urinary Incontinence, Mixed Urinary Incontinence); Distribution Channel (Offline Stores Distribution Channel, Online Distribution Channels); Usage (Reusable Usage, Disposable Usage); End-Use (Hospitals & Clinics End-Use, Homecare End-Use, Other End-Uses).
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Non-Absorbent Products segment, which is expected to reach US$5.7 Billion by 2032 with a CAGR of 6.0%. The Absorbent Products segment is also set to grow at 3.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $1.9 Billion in 2025, and China, forecasted to grow at an impressive 9.4% CAGR to reach $2.2 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Male Urinary Incontinence Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Male Urinary Incontinence Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Male Urinary Incontinence Market expected to evolve by 2032?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2032?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as A.M.I. GmbH (Agency for Medical Innovations), Attends (Domtar Personal Care), Becton, Dickinson and Company (BD), Boston Scientific Corporation, C.R. Bard, Inc. (A subsidiary of BD) and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the companies featured in this Male Urinary Incontinence market report include:
- A.M.I. GmbH (Agency for Medical Innovations)
- Attends (Domtar Personal Care)
- Becton, Dickinson and Company (BD)
- Boston Scientific Corporation
- C.R. Bard, Inc. (A subsidiary of BD)
- Caldera Medical
- Coloplast A/S
- Convatec Group plc
- Depend (Kimberly-Clark Corporation)
- First Quality Enterprises, Inc.
- Hollister Incorporated
- Johnson & Johnson
- Medtronic plc
- Men's Liberty (BioDerm, Inc.)
- NorthShore Care Supply
- Promedon Group
- SCA Hygiene Products AB
- TENA (Essity AB)
- Tranquility (Principle Business Enterprises, Inc.)
- Zephyr Surgical Implants
Domain Expert Insights
This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 43 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- A.M.I. GmbH (Agency for Medical Innovations)
- Attends (Domtar Personal Care)
- Becton, Dickinson and Company (BD)
- Boston Scientific Corporation
- C.R. Bard, Inc. (A subsidiary of BD)
- Caldera Medical
- Coloplast A/S
- Convatec Group plc
- Depend (Kimberly-Clark Corporation)
- First Quality Enterprises, Inc.
- Hollister Incorporated
- Johnson & Johnson
- Medtronic plc
- Men's Liberty (BioDerm, Inc.)
- NorthShore Care Supply
- Promedon Group
- SCA Hygiene Products AB
- TENA (Essity AB)
- Tranquility (Principle Business Enterprises, Inc.)
- Zephyr Surgical Implants
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 563 |
| Published | June 2026 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 6.1 Billion |
| Forecasted Market Value ( USD | $ 8.6 Billion |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
